Korsana Biosciences, Inc. KRSA
Set alert
31.66 USD +1.52 +5.04%
At close · Nov 2
31.66 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
29.93 Day range 31.91
7.19 52-week range 59.36
- YTD
- +256.13%
- 1 year
- +141.86%
- Open
- 30.00
- Prev close
- 30.14
- Mkt cap
- 1.44B
- Vol
- 197.55K
- Avg vol
- 75.45K
- EPS
- -7.07
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 29.93
- High
- 31.91
- Forward P/E
- -8.90
- Beta
- 1.84
- Short ratio
- 0.26
- Inst. own
- 45.26%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 11, 2026
- 50-d avg
- 31.09
- 200-d avg
- 21.95
- 1y target
- 44.00
MAX chart
Events in this range
- Aug 5, 2025Earnings: -0.11; estimate —; surprise —%
- Nov 12, 2025Earnings: -0.3; estimate -121.8; surprise 99.75%
- Mar 17, 2026Earnings: -1.75; estimate -2.66; surprise 34.21%
- May 5, 2026Earnings: -2.66; estimate -2.66; surprise 0%
- Aug 4, 2026Earnings: -0.41; estimate -3.45; surprise 88.12%
- Sep 11, 2026Rating: UBS · — → Buy
- Sep 14, 2026Rating: TD Cowen · — → Buy
- Sep 14, 2026Rating: Stifel · — → Buy
- Sep 28, 2026Rating: Guggenheim · — → Buy
- Oct 5, 2026Rating: Wedbush · — → Outperform
Signals (155)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 26, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 26, 2026 | 1 week ago |
| RSI: Overbought | Sep 14, 2026 | 1 month ago |
| SMA: Bullish | Jun 8, 2026 | 4 months ago |
| SMA: Bearish | May 25, 2026 | 5 months ago |
| SMA: Bullish | Mar 30, 2026 | 7 months ago |
| RSI: Overbought | Mar 30, 2026 | 7 months ago |
| SMA: Bullish | Mar 2, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 9, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 2, 2026 | 9 months ago |
| SMA: Bearish | Jan 26, 2026 | 9 months ago |
| SMA: Bullish | Jan 19, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 19, 2026 | 9 months ago |
| SMA: Bearish | Jan 12, 2026 | 9 months ago |
| SMA: Bullish | Jan 5, 2026 | 10 months ago |
| RSI: Oversold | Nov 10, 2025 | 11 months ago |
| SMA: Bearish | Oct 6, 2025 | 1 year ago |
| SMA: Bullish | Sep 29, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 28, 2025 | 1 year ago |
| SMA: Bearish | Jul 21, 2025 | 1 year ago |
Newest 20 of 155.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 44.00 +39.0% upside
Now 31.66
- Target (low)
- 8.00
- Target (mean)
- 44.00
- Target (high)
- 70.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
- Strong buy0
- Buy5
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next quarter | -0.67477 | -0.67477 – -0.67477 | 0.00 | 0.0% | 0 | 0.0% | 1 |
| Current year | -1.70 | -1.70 – -1.70 | 0.00 | 0.0% | 0 | -100.0% | 1 |
| Next year | -3.56 | -3.56 – -3.56 | -1.70 | -108.9% | 0 | 0.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 5, 2026 | Wedbush | Initiated | — | Outperform |
| Sep 28, 2026 | Guggenheim | Initiated | — | Buy |
| Sep 14, 2026 | Stifel | Initiated | — | Buy |
| Sep 14, 2026 | TD Cowen | Initiated | — | Buy |
| Sep 11, 2026 | UBS | Initiated | — | Buy |